文献速递心血管胸部CT

CT冠状动脉造影与动态CT心肌灌注成像检测心脏移植物血管病变

CT Coronary Angiography and Dynamic CT Myocardial Perfusion for Detection of Cardiac Allograft Vasculopathy.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-04-12

63例心脏移植患者接受CT-MPI联合CCTA及有创冠状动脉造影(ICA)与血管内超声(IVUS)检查,35例(55.6%)诊断为CAV;CAV患者MBFglobal和MBFmin中位数均显著低于无CAV者,CCTA冠状动脉狭窄联合MBFmin诊断CAV的AUC为0.886(敏感度74.3%,特异度96.4%,阳性预测值96.3%,阴性预测值75.0%)。

要点

  • CAV患者MBFglobal中位数128.7 vs 150.4 mL/100 mL/min(P=0.014),MBFmin中位数96.9 vs 122.8 mL/100 mL/min(P<0.001),均显著降低。
  • CCTA冠状动脉狭窄联合MBFmin诊断CAV的AUC为0.886,敏感度74.3%,特异度96.4%,阳性预测值96.3%,阴性预测值75.0%。
  • CCTA联合CT-MPI一站式评估冠状动脉及微血管成分,可能作为CAV早期检测的无创筛查方法。

核心结论

  • CT-MPI联合CCTA检测CAV表现出极佳的诊断效能,一站式评估CAV累及的冠状动脉及微血管成分可能成为CAV早期检测的有效无创筛查方法。

研究设计与样本

  • 研究纳入2018年12月至2021年10月间63例心脏移植患者,均接受CT-MPI联合CCTA检查以及有创冠状动脉造影(ICA)和血管内超声(IVUS)检查;CT-MPI与心脏移植的中位间隔时间为4.3年;CAV诊断基于ICA(ISHLT标准)和IVUS。

诊断标准与关键数值

  • CAV诊断基于ICA(ISHLT标准)和IVUS;CT-MPI计算全心肌峰值心肌血流量(MBFglobal)及按美国心脏协会模型16节段(除外左心室心尖)的最小MBF(MBFmin);CCTA定性评估并记录冠状动脉狭窄程度;CCTA冠状动脉狭窄联合MBFmin诊断CAV的AUC为0.886,敏感度74.3%,特异度96.4%,阳性预测值96.3%,阴性预测值75.0%。

临床应用与阅片要点

  • 作者认为,联合CCTA和CT-MPI一站式评估CAV累及的冠状动脉及微血管成分,可能作为CAV早期检测的有效无创筛查方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a major obstacle limiting long-term graft survival. Effective noninvasive surveillance modalities reflecting both coronary artery and microvascular components of CAV are needed.

OBJECTIVES: The authors evaluated the diagnostic performance of dynamic computed tomography-myocardial perfusion imaging (CT-MPI) and coronary computed tomography angiography (CCTA) for CAV.

METHODS: A total of 63 heart transplantation patients underwent combined CT-MPI and CCTA plus invasive coronary angiography (ICA) with intravascular ultrasonography (IVUS) between December 2018 and October 2021. The median interval between CT-MPI and heart transplantation was 4.3 years. Peak myocardial blood flow (MBF) of the whole myocardium (MBFglobal) and minimum MBF (MBFmin) among the 16 segments according to the American Heart Association model, except the left ventricular apex, were calculated from CT-MPI. CCTA was assessed qualitatively, and the degree of coronary artery stenosis was recorded. CAV was diagnosed based on both ICA (ISHLT criteria) and IVUS. Patients were followed up for a median time of 2.3 years after CT-MPI and a median time of 5.7 years after transplantation.

RESULTS: Among the 63 recipients, 35 (55.6%) had diagnoses of CAV. The median MBFglobal and MBFmin were significantly lower in patients with CAV (128.7 vs 150.4 mL/100 mL/min; P = 0.014; and 96.9 vs 122.8 mL/100 mL/min; P < 0.001, respectively). The combined use of coronary artery stenosis on CCTA and MBFmin showed the highest diagnostic performance with an area under the curve of 0.886 (sensitivity: 74.3%, specificity: 96.4%, positive predictive value: 96.3%, and negative predictive value: 75.0%).

CONCLUSIONS: The combination of CT-MPI and CCTA demonstrated excellent diagnostic performance for the detection of CAV. One-stop evaluation of the coronary artery and microvascular components involved in CAV using combined CCTA and CT-MPI may be a potent noninvasive screening method for early detection of CAV.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Ahn, Koo, Hyun, et al. CT Coronary Angiography and Dynamic CT Myocardial Perfusion for Detection of Cardiac Allograft Vasculopathy. JACC Cardiovasc Imaging. 2023. PMID: 37407125. doi:10.1016/j.jcmg.2022.12.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。